Insud Pharma is a company providing pharmaceutical solutions for the entire life cycle of a medicine.
INSUD PHARMA operates across the entire pharmaceutical value chain, delivering specialized expertise and experience in scientific research, development, manufacturing, sales and marketing of a wide range of value-adding active pharmaceutical ingredients (APIs), finished dosage forms (FDFs) and branded pharmaceuticals, for human and animal health.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Aug 12, 2022
Greenlight Biosciences
|
Post-IPO Equity | $109M | Agriculture | — |